05/08/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 5:30 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2024 1:30 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/20/2024 7:07 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 8:30 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/21/2023 6:35 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 4:30 PM | OKYO Pharma (Filer)
| Form 424B5 | |
12/18/2023 3:56 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/29/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023 3:55 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023 3:59 PM | OKYO Pharma (Filer)
| Form 424B5 | |
10/31/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/05/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/28/2023 5:15 AM | BRANCACCIO JOHN P (Reporting) OKYO Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 3:05 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023 5:05 AM | OKYO Pharma (Filer)
| Form 424B5 | |
09/14/2023 9:03 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023 9:05 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2023 3:05 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2023 3:13 PM | OKYO Pharma (Filer)
| Form 424B5 | |
09/08/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/25/2023 10:33 AM | OKYO Pharma (Filer)
| Form 20-F/A | |
08/15/2023 8:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023 5:02 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023 4:24 PM | OKYO Pharma (Filer)
| Form 424B5 | |
07/28/2023 4:25 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023 4:25 PM | OKYO Pharma (Subject)
| Form FWP | |
07/28/2023 4:05 PM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023 6:00 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
06/15/2023 3:10 PM | OKYO Pharma (Filer)
| Form 424B3 | |
06/14/2023 11:15 PM | OKYO Pharma (Filer)
| Form EFFECT | |
06/14/2023 11:15 PM | OKYO Pharma (Filer)
| Form EFFECT | |
06/08/2023 3:31 PM | OKYO Pharma (Filer)
| Form F-1/A | |
06/06/2023 8:30 AM | OKYO Pharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023 4:30 PM | OKYO Pharma (Filer)
| Form F-1/A | |